Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Safety of Perfluorobutane (Sonazoid) in Characterizing Focal Liver Lesions.

< BACK TO ARCHIVE


2019 Apr-Jun


J Med Ultrasound


http://www.ncbi.nlm.nih.gov/pubmed/31316217?dopt=Abstract


27


2

Safety of Perfluorobutane (Sonazoid) in Characterizing Focal Liver Lesions.

Authors

Safety of Perfluorobutane (Sonazoid) in Characterizing Focal Liver Lesions.
Chou Y-H, Liang J-D, Wang S-Y, Hsu S-J, Hu J-T, Yang S-S, Wang H-K, Lee T-Y, Tiu C-M
J Med Ultrasound. 2019 Apr-Jun; 27(2):81-85.
PMID: 31316217.

Abstract

The purpose of this study was to report the safety of perfluorobutane (Sonazoid) as a vascular-phase imaging agent in characterizing focal liver lesions (FLLs).
Read This Paper